Cargando…
Biochemical characterization of the PHARC-associated serine hydrolase ABHD12 reveals its preference for very-long-chain lipids
Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC) is a rare genetic human neurological disorder caused by null mutations to the Abhd12 gene, which encodes the integral membrane serine hydrolase enzyme ABHD12. Although the role that ABHD12 plays in PHARC is understood,...
Autores principales: | Joshi, Alaumy, Shaikh, Minhaj, Singh, Shubham, Rajendran, Abinaya, Mhetre, Amol, Kamat, Siddhesh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217928/ https://www.ncbi.nlm.nih.gov/pubmed/30237167 http://dx.doi.org/10.1074/jbc.RA118.005640 |
Ejemplares similares
-
A Chemical Genetic Screen Identifies ABHD12 as an Oxidized Phosphatidylserine Lipase
por: Kelkar, Dhanashree S., et al.
Publicado: (2019) -
The loss of enzymatic activity of the PHARC‐associated lipase ABHD12 results in increased phagocytosis that causes neuroinflammation
por: Singh, Shubham, et al.
Publicado: (2021) -
α/β Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate
por: Pribasnig, Maria A., et al.
Publicado: (2015) -
The Phenotypic Spectrum of Patients with PHARC Syndrome Due to Variants in ABHD12: An Ophthalmic Perspective
por: Nguyen, Xuan-Thanh-An, et al.
Publicado: (2021) -
Genetic insights into PHARC syndrome: identification of a novel frameshift mutation in ABHD12
por: Daneshi, Ahmad, et al.
Publicado: (2023)